Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Nov;14(10):1159-63.
doi: 10.3109/14653249.2012.729817.

Is CD34 truly a negative marker for mesenchymal stromal cells?

Affiliations
Review

Is CD34 truly a negative marker for mesenchymal stromal cells?

Ching-Shwun Lin et al. Cytotherapy. 2012 Nov.

Abstract

The prevailing school of thought is that mesenchymal stromal cells (MSC) do not express CD34, and this sets MSC apart from hematopoietic stem cells (HSC), which do express CD34. However, the evidence for MSC being CD34(-) is largely based on cultured MSC, not tissue-resident MSC, and the existence of CD34(-) HSC is in fact well documented. Furthermore, the Stro-1 antibody, which has been used extensively for the identification/isolation of MSC, was generated by using CD34(+) bone marrow cells as immunogen. Thus, neither MSC being CD34(-) nor HSC being CD34(+) is entirely correct. In particular, two studies that analyzed CD34 expression in uncultured human bone marrow nucleated cells found that MSC (BMSC) existed in the CD34(+) fraction. Several studies have also found that freshly isolated adipose-derived MSC (ADSC) express CD34. In addition, all of these ADSC studies and several other MSC studies have observed a disappearance of CD34 expression when the cells are propagated in culture. Thus the available evidence points to CD34 being expressed in tissue-resident MSC, and its negative finding being a consequence of cell culturing.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

    1. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204–13. - PubMed
    1. Lin CS, Lue TF. Adipose-Derived Stem Cells: Characterization and Application in Urology. In: Illouz YG, Sterodimas A, editors. Adipose Stem Cells and Regenerative Medicine. New York, NY: Springer; 2011. pp. 193–207.
    1. Lin CS, Lue TF. Adipose-Derived Stem Cells: Therapy through Paracrine Actions. In: Hayat MA, editor. Stem Cells and Cancer Stem Cells. Vol. 4. New York, NY: Springer; 2012. pp. 203–16.
    1. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100:1249–60. - PMC - PubMed
    1. Lin G, Garcia M, Ning H, Banie L, Guo YL, Lue TF, et al. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 2008;17:1053–63. - PMC - PubMed

Publication types

MeSH terms